期刊
CHEMICAL COMMUNICATIONS
卷 -, 期 47, 页码 4978-4991出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/b707257k
关键词
-
资金
- NATIONAL CANCER INSTITUTE [R01CA098945] Funding Source: NIH RePORTER
- NCI NIH HHS [1R01 CA098945] Funding Source: Medline
Neutron capture therapy (NCT) is a binary radio-chemotherapeutic modality for the treatment of cancer. A major focus of NCT-related research is the development of novel tumor-selective agents that serve as the chemical component in NCT. Thymidine analogues substituted with a boron-containing carborane cluster at the N3 position, designated 3CTAs (3-carboranyl thymidine analogues), constitute one class of these new improved NCT agents. Their chemical, structural and biological properties are discussed in this Feature Article.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据